GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemogenyx Pharmaceuticals PLC (LSE:HEMO) » Definitions » Other Assets for Insurance Companies

Hemogenyx Pharmaceuticals (LSE:HEMO) Other Assets for Insurance Companies


View and export this data going back to 2015. Start your Free Trial

What is Hemogenyx Pharmaceuticals Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


Hemogenyx Pharmaceuticals Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Hemogenyx Pharmaceuticals PLC is an operator of a biotechnology company intended to focus on the discovery, development, and commercialization of novel therapies and treatments for blood diseases, like leukaemia and lymphoma. The company's technology has the motive to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy, its three distinct products include an immunotherapy product for the treatment of relapsed/refractory acute myeloid leukaemia (AML) and patient conditioning, the bi-specific antibody, for the treatment of AML and a community-based rehabilitation/Biomedical engineering platform, enabling users to generate treatments for existing and emerging viral infections.